THC BioMed Intl Ltd. (CSE: THC) ("THC BioMed" or the "Company") is pleased to report its financial results for the three months ended October 31, 2021 . Q1 HIGHLIGHTS Produced a gross margin profit after fair value adjustments of $711,761 and net income of $25,006 Sales revenue increased 83% period to period Sales of edibles... Read More